CN Stock MarketDetailed Quotes

Hinova Pharmaceuticals Inc. (688302)

Watchlist
  • 46.43
  • -1.16-2.44%
Market Closed Apr 17 15:00 CST
4.60BMarket Cap-31.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hinova Pharmaceuticals Inc. (688302) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Drugs13.07M99.25%
材料及研发中间体销售98.39K0.75%

By Industry

No Data

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Territory area13.17M100.00%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -